SCHEMBL9080888

SCHEMBL9080888

COc1ccccc1-c1c[nH]c(SC)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.49
METAP2 P50579 1/20 0.46
ALDH1A1 P00352 4/20 0.46
GAA P10253 2/20 0.46
HPGD P15428 2/20 0.46
MAPT P10636 1/20 0.46
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HSP90AA1 P07900 2/20 0.43
DCUN1D1 Q96GG9 2/20 0.43
HSP90AB1 P08238 1/20 0.42
KMT2A Q03164 1/20 0.42
APP P05067 1/20 0.42
PDGFRB P09619 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP19A1 P11511 1/20 0.40
CHRNA7 P36544 1/20 0.39
C1S P09871 1/20 0.39
ADORA2A P29274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16481851 0.79 HSP90AA1 (0.50) ALPLMETAP2ALDH1A1GAAHPGD
SCHEMBL9731133 0.79 DCUN1D1 (0.53) ALPLMETAP2ALDH1A1GAAHPGD
SCHEMBL1408091 0.78 HSP90AA1 (0.53) METAP2ALDH1A1GAAHPGDMAPT
SCHEMBL11046550 0.77 METAP2 (0.45) ALPLMETAP2ALDH1A1GAAHPGD
SCHEMBL10825645 0.77 PKM (0.50) ALPLALDH1A1HSP90AA1DCUN1D1HSP90AB1
SCHEMBL3932920 0.74 PDGFRB (0.49) METAP2ALDH1A1GAAHPGDMAPT
SCHEMBL2818901 0.72 SQOR (0.51) METAP2ALDH1A1GAAHPGDMAPT
SCHEMBL8657051 0.72 HSP90AA1 (0.41) ALPLMETAP2ALDH1A1GAAHPGD
SCHEMBL4395803 0.71 METAP2 (0.42) ALPLMETAP2ALDH1A1GAAHPGD
SCHEMBL3629826 0.70 ALDH1A1 (0.57) METAP2ALDH1A1GAAHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996003387-A1 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed